We are live on ! Find out more
OC

Oakworth Capital Portfolio holdings

AUM $2.1B
1-Year Est. Return 24.07%
This Fund
S&P 500
This Quarter Est. Return
-0.25%
1 Year Est. Return
+24.07%
3 Year Est. Return
+64.28%
5 Year Est. Return
+64.42%
10 Year Est. Return
+240.11%
AUM
$1.45B
AUM Growth
+$11M
Cap. Flow
+$24.8M
Cap. Flow %
1.71%
Top 10 Hldgs %
61.57%
Holding
694
New
26
Increased
100
Reduced
172
Closed
65

Sector Composition

Rank Sector Weight
1 Technology 7.05%
2 Financials 6.18%
3 Industrials 4.37%
4 Consumer Staples 3.57%
5 Communication Services 2.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSX icon
126
CSX Corp
CSX
$93.4B
$495K 0.03%
15,344
+7,898
+106% +$271K
AMAT icon
127
Applied Materials
AMAT
$403B
$488K 0.03%
2,998
JOE icon
128
St. Joe Company
JOE
$3.54B
$463K 0.03%
10,296
-39
-0.4% -$2.02K
GPC icon
129
Genuine Parts
GPC
$17.1B
$455K 0.03%
3,900
+33
+0.9% +$4.12K
NPO icon
130
Enpro
NPO
$6.63B
$449K 0.03%
2,601
WFC icon
131
Wells Fargo
WFC
$261B
$437K 0.03%
6,228
ACN icon
132
Accenture
ACN
$102B
$436K 0.03%
1,239
-6
-0.5% -$2.16K
MMM icon
133
3M
MMM
$90.9B
$428K 0.03%
3,316
-53
-2% -$6.95K
STLD icon
134
Steel Dynamics
STLD
$36B
$424K 0.03%
3,721
CTRA
135
DELISTED
Coterra Energy
CTRA
$419K 0.03%
16,396
UPS icon
136
United Parcel Service
UPS
$88.6B
$411K 0.03%
3,257
-152
-4% -$20K
EMR icon
137
Emerson Electric
EMR
$83.9B
$406K 0.03%
3,274
-393
-11% -$47.7K
MDLZ icon
138
Mondelez International
MDLZ
$79.5B
$401K 0.03%
6,713
+828
+14% +$54.8K
VTV icon
139
Vanguard Morningstar Value ETF
VTV
$188B
$399K 0.03%
2,359
BSX icon
140
Boston Scientific
BSX
$69.5B
$398K 0.03%
4,457
IBB icon
141
iShares Biotechnology ETF
IBB
$9.34B
$397K 0.03%
3,000
XLE icon
142
State Street Energy Select Sector SPDR ETF
XLE
$39.6B
$395K 0.03%
9,212
+6,958
+309% +$316K
APD icon
143
Air Products & Chemicals
APD
$65.7B
$393K 0.03%
1,355
AMGN icon
144
Amgen
AMGN
$208B
$392K 0.03%
1,505
UTHR icon
145
United Therapeutics
UTHR
$25.8B
$392K 0.03%
1,111
HRMY icon
146
Harmony Biosciences
HRMY
$2.04B
$383K 0.03%
11,127
+1,452
+15% +$49.9K
NBIX icon
147
Neurocrine Biosciences
NBIX
$16.8B
$379K 0.03%
+2,774
New +$343K
ADSK icon
148
Autodesk
ADSK
$49.5B
$376K 0.03%
1,271
RSPT icon
149
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$5.49B
$374K 0.03%
10,000
GILD icon
150
Gilead Sciences
GILD
$162B
$370K 0.03%
4,006
-300
-7% -$27K

Similar funds

Oakworth Capital's Q4 2024 Portfolio in Review

As of Q4 2024, Oakworth Capital held 694 positions worth $1.45B, up 0.76% from $1.44B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Oakworth Capital's Q4 2024 filing shows 26 new, 100 increased, 172 reduced and 65 closed positions. Its largest new stake was Neurocrine Biosciences: 2,774 shares worth $379K. The largest sale was Regions Financial, an estimated $3.18M.

By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 6.7% a quarter earlier, followed by Financials and Industrials.

  • Oakworth Capital's largest Q4 2024 buy was Neurocrine Biosciences: 2,774 shares worth $379K.
  • Oakworth Capital added most to Vanguard Total Bond Market in Q4 2024, an estimated $5.57M increase.
  • Oakworth Capital's biggest Q4 2024 reduction was Regions Financial, cutting an estimated $3.18M.
  • Oakworth Capital fully exited iShares National Muni Bond ETF in Q4 2024, selling an estimated $769K.
  • Oakworth Capital's ten largest holdings make up 62% of its $1.45B portfolio in Q4 2024.
  • Oakworth Capital opened 26 new positions and closed 65 in Q4 2024.
  • Oakworth Capital's portfolio value rose 0.76% quarter-over-quarter to $1.45B.

Based on Oakworth Capital's 13F filing for Q4 2024, filed 27 Jan 2025.